Hox Therapeutics appoints Karl Keegan as CEOHox Therapeutics has announced the appointment of Dr Karl Keegan as Chief Executive Officer. more ➔
Adrienne Graves joins Oxurion’s BoardOxurion NV (formerly known as ThromboGenics NV), a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye, announced today the appointment … more ➔
Zelluna appoints new CFOZelluna Immunotherapy has announced the appointment of Geir Christian Melen as chief financial officer (CFO). more ➔
Aglaris Appoints New CEOAglaris Ltd. yesterday announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish cell therapy equipment manufacturer, effective immediately. more ➔
Exscientia Appoints Georgy Egorov as CFOExscientia, a company in Artificial Intelligence (AI)-driven drug discovery, has announced the appointment of Mr Georgy Egorov as Chief Financial Officer (CFO). more ➔
Pfizer CEO announces SuccessionPfizer Inc. today announced its Board of Directors has unanimously elected Dr. Albert Bourla, 56, Pfizer Chief Operating Officer (COO), to succeed Ian Read as CEO effective January 1, 2019. Ian Read … more ➔
Ysios Capital appoints Guillem LaportaYsios Capital, a biotechnology venture capital firm in Spain, today announced that it has appointed Guillem Laporta as Principal. more ➔
Virion Appoints Vanessa King as President & CEOVirion Biotherapeutics announced the appointments of Vanessa King, PhD, as President & Chief Executive Officer this week. more ➔
Carl Bjartmar appointed as CMO for Ascelia Pharma Ascelia Pharma announced on Friday Spetember 14 that Carl Bjartmar, MD, PhD, has been appointed as new Chief Medical Officer (CMO) for Ascelia Pharma. Carl has most recently worked as CMO for Wilson … more ➔
Torbjørn Furuseth joins Targovax as CFOTargovax ASA (Targovax or the Company; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, announces the appointment of Dr. Torbjørn … more ➔
